BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 25967458)

  • 1. EMMPRIN in gynecologic cancers: pathologic and therapeutic aspects.
    Liu DT
    Tumour Biol; 2015 Jul; 36(7):4883-8. PubMed ID: 25967458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lentivirus mediated RNA interference of EMMPRIN (CD147) gene inhibits the proliferation, matrigel invasion and tumor formation of breast cancer cells.
    Yang J; Wang R; Li H; Lv Q; Meng W; Yang X
    Cancer Biomark; 2016 Jul; 17(2):237-47. PubMed ID: 27434292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extracellular matrix metalloproteinase inducer stimulates tumor angiogenesis by elevating vascular endothelial cell growth factor and matrix metalloproteinases.
    Tang Y; Nakada MT; Kesavan P; McCabe F; Millar H; Rafferty P; Bugelski P; Yan L
    Cancer Res; 2005 Apr; 65(8):3193-9. PubMed ID: 15833850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression and clinical significance of CD147 in genitourinary carcinomas.
    Han ZD; He HC; Bi XC; Qin WJ; Dai QS; Zou J; Ye YK; Liang YX; Zeng GH; Zhu G; Chen ZN; Zhong WD
    J Surg Res; 2010 May; 160(2):260-7. PubMed ID: 19286191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Receptor activator of NF-kappaB ligand enhances breast cancer-induced osteolytic lesions through upregulation of extracellular matrix metalloproteinase inducer/CD147.
    Rucci N; Millimaggi D; Mari M; Del Fattore A; Bologna M; Teti A; Angelucci A; Dolo V
    Cancer Res; 2010 Aug; 70(15):6150-60. PubMed ID: 20631064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel functional site of extracellular matrix metalloproteinase inducer (EMMPRIN) that limits the migration of human uterine cervical carcinoma cells.
    Sato T; Watanabe M; Hashimoto K; Ota T; Akimoto N; Imada K; Nomizu M; Ito A
    Int J Oncol; 2012 Jan; 40(1):236-42. PubMed ID: 21994090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of EMMPRIN in adenoid cystic carcinoma of salivary glands: correlation with tumor progression and patients' prognosis.
    Yang X; Dai J; Li T; Zhang P; Ma Q; Li Y; Zhou J; Lei D
    Oral Oncol; 2010 Oct; 46(10):755-60. PubMed ID: 20850374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emmprin (basigin/CD147): matrix metalloproteinase modulator and multifunctional cell recognition molecule that plays a critical role in cancer progression.
    Nabeshima K; Iwasaki H; Koga K; Hojo H; Suzumiya J; Kikuchi M
    Pathol Int; 2006 Jul; 56(7):359-67. PubMed ID: 16792544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of tumor cell growth in vivo by extracellular matrix metalloprotease inducer.
    Newman JR; Bohannon IA; Zhang W; Skipper JB; Grizzle WE; Rosenthal EL
    Arch Otolaryngol Head Neck Surg; 2008 Nov; 134(11):1218-24. PubMed ID: 19015455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downregulation of Extracellular Matrix Metalloproteinase Inducer by scFv-M6-1B9 Intrabody Suppresses Cervical Cancer Invasion Through Inhibition of Urokinase-Type Plasminogen Activator.
    Panich T; Tragoolpua K; Pata S; Tayapiwatana C; Intasai N
    Cancer Biother Radiopharm; 2017 Feb; 32(1):1-8. PubMed ID: 28118037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upregulation of extracellular matrix metalloproteinase inducer promotes hypoxia-induced epithelial-mesenchymal transition in esophageal cancer.
    Wu X; Qiao B; Liu Q; Zhang W
    Mol Med Rep; 2015 Nov; 12(5):7419-24. PubMed ID: 26458866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High incidence of extracellular matrix metalloproteinase inducer expression in non-small cell lung cancers. Association with clinicopathological parameters.
    Hakuma N; Betsuyaku T; Kinoshita I; Itoh T; Kaga K; Kondo S; Nishimura M; Dosaka-Akita H
    Oncology; 2007; 72(3-4):197-204. PubMed ID: 18160808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extracellular matrix metalloproteinase inducer regulates metalloproteinases in human uterine endometrium.
    Braundmeier AG; Fazleabas AT; Lessey BA; Guo H; Toole BP; Nowak RA
    J Clin Endocrinol Metab; 2006 Jun; 91(6):2358-65. PubMed ID: 16522689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extracellular matrix metalloproteinase inducer regulates matrix metalloproteinase activity in cardiovascular cells: implications in acute myocardial infarction.
    Schmidt R; Bültmann A; Ungerer M; Joghetaei N; Bülbül O; Thieme S; Chavakis T; Toole BP; Gawaz M; Schömig A; May AE
    Circulation; 2006 Feb; 113(6):834-41. PubMed ID: 16461815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor-stroma interaction: positive feedback regulation of extracellular matrix metalloproteinase inducer (EMMPRIN) expression and matrix metalloproteinase-dependent generation of soluble EMMPRIN.
    Tang Y; Kesavan P; Nakada MT; Yan L
    Mol Cancer Res; 2004 Feb; 2(2):73-80. PubMed ID: 14985463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of CD147 gene expression via RNA interference reduces tumor cell invasion, tumorigenicity and increases chemosensitivity to paclitaxel in HO-8910pm cells.
    Zou W; Yang H; Hou X; Zhang W; Chen B; Xin X
    Cancer Lett; 2007 Apr; 248(2):211-8. PubMed ID: 16930823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytokines regulate matrix metalloproteinases in human uterine endometrial fibroblast cells through a mechanism that does not involve increases in extracellular matrix metalloproteinase inducer.
    Braundmeier AG; Nowak RA
    Am J Reprod Immunol; 2006 Sep; 56(3):201-14. PubMed ID: 16911716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of extracellular matrix metalloproteinase inducer (EMMPRIN) and its expected roles in the bovine endometrium during gestation.
    Mishra B; Kizaki K; Koshi K; Ushizawa K; Takahashi T; Hosoe M; Sato T; Ito A; Hashizume K
    Domest Anim Endocrinol; 2012 Feb; 42(2):63-73. PubMed ID: 22032855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EMMPRIN/CD147, an MMP modulator in cancer, development and tissue repair.
    Gabison EE; Hoang-Xuan T; Mauviel A; Menashi S
    Biochimie; 2005; 87(3-4):361-8. PubMed ID: 15781323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of vascular endothelial growth factor expression by EMMPRIN via the PI3K-Akt signaling pathway.
    Tang Y; Nakada MT; Rafferty P; Laraio J; McCabe FL; Millar H; Cunningham M; Snyder LA; Bugelski P; Yan L
    Mol Cancer Res; 2006 Jun; 4(6):371-7. PubMed ID: 16778084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.